PROGRAM MANAGER: Jonathan Jakischa
OPPORTUNITY: Joint Development, Contract Research, Technology Acquisition, Technology Licensing, Supply Agreement, Consulting, To Be Negotiated
Phase 1 – Proof of concept in 6-12 months
Phase 2 – Industrial evaluation in 6-12 months
Phase 1 – Proof of concept funding commensurate with proposed activity
SOLUTION PROVIDER HELP DESK:
NineSigma, representing a global consumer product company, invites proposals for technologies capable of deactivating naturally-occurring nitrosamines during processing and storage.
Nitrosamines are compounds that are produced naturally by a variety of products, including plants, processed meats and other products. These compounds have the potential for serious negative health impacts.
Nitrosamine formation can occur on the surface as well as internally inside cells. Additionally, the levels of these compounds can increase during storage or during the production cycle.
NineSigma’s client processes nearly 800 million pounds of base material annually into a consumable product. Consequently, a mechanism, such as photo-deactivation of the nitrosamine compounds, to treat the material is highly desirable. Treatment may occur after the initial processing stage, prior to storage or both.
Conceptual technologies, as well as more established approaches, are of interest for this request.
Anticipated Project Phases or Project Plan
Phase 1 – Proof of concept
Phase 2 – Commercial development
Criteria for Moving from Phase 1 to Phase 2
Client will consider for advancement an approach that meets performance criteria with acceptable economics and pathway to commercialization.
The successful technology will:
NineSigma’s client is open to all approaches with the ability to reduce or eliminate the production of nitrosamines.
Any technology which negatively impacts the integrity of the base materials.
To respond, please make sure you are registered in NineSights, as it will prompt you to log in. Then, use the Response options at the top or bottom of the page. You may submit supplemental files in addition to your completed response form.
Appropriate responses will use the response form and address the following:
Other Request information includes:
APPROPRIATE RESPONSES TO THIS REQUEST
Responses from companies (small to large), academic researchers, other research institutes, consultants, venture capitalists, entrepreneurs, or inventors are welcome. For example:
You represent a company or university that has demonstrated a proof of concept.
You represent a company or university that has reduced method to practice at lab scale.
You represent a company or university that has developed a method for use at pilot scale.
You represent a company or university that has demonstrated a method ready for implementation at industrial scale.
You represent a university research department that has a bench-scale demonstration ready to adapt.
You represent a university research department that has an undeveloped pathway with a high probability of success.